Harmony Biosciences to Participate in Upcoming Investor Conferences
Harmony Biosciences (Nasdaq: HRMY) said its management team will attend three investor conferences in Miami, FL on March 9–10, 2026: Leerink Partners Global Healthcare Conference, UBS Biotech Summit, and Barclays 28th Annual Global Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Leerink Partners Global Healthcare Conference
- Date: March 9, 2026
-
Location:
Miami, FL
UBS Biotech Summit
- Date: March 9, 2026
-
Location:
Miami, FL
Barclays 28th Annual Global Healthcare Conference
- Date: March 10, 2026
-
Location:
Miami, FL
About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20260304620056/en/
Harmony Biosciences Investor Contact:
Matthew Beck
917-415-1750
matthew.beck@astrpartners.com
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com
Source: Harmony Biosciences Holdings, Inc.